Irritable Bowel Syndrome Clinical Trial
— IBS_FBMOfficial title:
A Pilot Study on the Effect of Electroacupuncture on Functional Brain Mapping in Patients With Irritable Bowel Syndrome
| Verified date | June 2009 |
| Source | Chinese University of Hong Kong |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
Irritable bowel syndrome (IBS) is the most common digestive disorder that affects more than
5% of population in Hong Kong. However, there is no effective treatment of IBS using Western
Medicine. Acupuncture, a traditional therapeutic modality, has been used in China for
thousands of years for various pain disorders. In addition to analgesia, acupuncture has
also been shown to influence physiology of gastrointestinal tract. The investigators set out
to evaluate the therapeutic value of acupuncture in IBS. The investigators will study its
effects on rectal sensation and brain activity in patients with IBS.
All patients will be evaluated for study eligibility at visit 1 (baseline). Baseline
assessment includes individual IBS symptoms (pain/discomfort, bloating, constipation, and
diarrhea) as perceived by patients will be scored. The syndrome of IBS patients will also be
recorded and analyzed based on the Chinese medicine theories. All patients will then undergo
baseline rectal barostat for thresholds of rectal sensation. At visit 2, eligible patients
will be randomly assigned to either (1) electroacupuncture or (2) sham electroacupuncture
treatment groups. Functional Magnetic Resonance Imaging (fMRI) scanning will be performed
before, during and after the electroacupuncture or sham electroacupuncture treatment.
| Status | Completed |
| Enrollment | 42 |
| Est. completion date | December 2008 |
| Est. primary completion date | December 2008 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years to 65 Years |
| Eligibility |
Inclusion Criteria: - Irritable bowel syndrome of diarrhea type as defined by Rome III criteria - Age 18-65 years - Normal colonic evaluation within 12 months (with either colonoscopy or barium study) Exclusion Criteria: - IBS-constipation, mixed or unsubtyped - Pregnancy - Medical history of organic colonic bowel disease - History of sensitivity to acupuncture - Psychiatric or additive disorder - Patients who have received acupuncture in the past 6 months - Concomitant medications including anti-diarrhea agent, anti-depressant, narcotic analgesic and anti-cholinergic |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| China | The Chinese University of Hong Kong, Prince of Wales Hospital | Shatin, Hong Kong |
| Lead Sponsor | Collaborator |
|---|---|
| Chinese University of Hong Kong | National Institutes of Health (NIH) |
China,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Sensory and pain thresholds as determined by rectal barostat | At baseline study visit | No | |
| Primary | Degree of cortical activation as determined by functional MRI | At study visit 2 | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03720314 -
Microbiota Profiling in IBS
|
||
| Recruiting |
NCT06166563 -
Exercise, Irritable Bowel Syndrome and Fibromyalgia
|
N/A | |
| Completed |
NCT05213910 -
Study of a Management Strategy of Functional Bowel Disordes Related to Irritable Bowel Syndrome (IBS) With a Mixture of 8 Microbiotic Strains
|
N/A | |
| Recruiting |
NCT05985018 -
Traditional Dietary Advice Vs. Mediterranean Diet in IBS
|
N/A | |
| Completed |
NCT04486469 -
Efficacy of Physiotherapy Techniques on Irritable Bowel Syndrome (IBS). Pilot Study.
|
N/A | |
| Completed |
NCT06407609 -
Positive Outcomes of the Supplementation With Lecithin-based Delivery Form of Curcuma Longa and of Boswellia Serrata in IBS
|
N/A | |
| Completed |
NCT04656730 -
Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas
|
Phase 4 | |
| Completed |
NCT04145856 -
Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico
|
Phase 4 | |
| Recruiting |
NCT04138225 -
The Ecological Role of Yeasts in the Human Gut
|
||
| Active, not recruiting |
NCT03586622 -
One Year Home Monitoring and Treatment of IBS Patients
|
N/A | |
| Completed |
NCT05207618 -
Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant
|
N/A | |
| Not yet recruiting |
NCT06369753 -
Visible Abdominal Distension
|
N/A | |
| Not yet recruiting |
NCT05157867 -
In Vivo Effects of Amylase Trypsin Inhibitors
|
N/A | |
| Not yet recruiting |
NCT05100719 -
The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)
|
N/A | |
| Recruiting |
NCT05001997 -
Effects of Lactose-free Dairy Products on Athletes With Irritable Bowel Syndrome
|
N/A | |
| Recruiting |
NCT02953171 -
Probiotics in the Treatment of Irritable Bowel Syndrome
|
N/A | |
| Completed |
NCT03266068 -
Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
|
||
| Completed |
NCT02977975 -
Lacto-fermented Sauerkraut in the Treatment of Irritable Bowel Syndrome
|
N/A | |
| Completed |
NCT02980406 -
The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level
|
N/A | |
| Completed |
NCT03318614 -
Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster
|
Phase 2/Phase 3 |